Pawel Francizek M.
- Country
- Norway
- Department
- Rheumatologic dept.
Research Overview
- Evaluation of Proactive Therapeutic Drug Monitoring Versus Standard Care in Sustaining Disease Control in Rheumatoid Arthritis Patients on Subcutaneous Adalimumab
- Phase 2 Study on the Efficacy of Alpelisib and Drug Combinations in Advanced Cancer with Genomic or Protein Expression Variants in Norway
- A randomized, phase II, open-label, multicenter study investigating efficacy and safety of anti-PD-1/PD-L1 treatment +/- UV1 vaccination as first line treatment in patients with inoperable advanced or metastatic non-small cell lung cancer
Data & Insights
Has run more than one trial at 14 of 30 partner sites.
Specializations
Rheumatology Focus
The investigator specializes in the treatment of rheumatoid arthritis, with particular emphasis on advancing therapeutic monitoring approaches in TNF inhibitor treatments.
- Therapeutic Drug Monitoring
- Disease Control Management
- Subcutaneous TNF Inhibitor Therapy
Their work centers on optimizing treatment outcomes through proactive monitoring strategies in rheumatoid arthritis care.
Precision Oncology
The investigator focuses on implementing precision medicine approaches in cancer care, particularly exploring targeted therapies based on genomic and protein expression variants.
- Targeted Anti-Cancer Treatments
- Genomic-Based Therapy Selection
- Advanced Malignancy Management
Their research aims to enhance public cancer care through personalized treatment approaches.
Lung Cancer Immunotherapy
The investigator specializes in innovative treatments for non-small cell lung cancer, focusing on combined immunotherapy approaches including PD-1/PD-L1 inhibitor treatments.
- Advanced Stage NSCLC Treatment
- Vaccination Strategies
- Combination Immunotherapy
Their work explores novel therapeutic combinations for advanced and metastatic lung cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.